Protein biomarkers in drug discovery and development

Uncovering novel protein biomarkers in drug discovery and development: Targeting disease diagnosis and drug response monitoring

Speakers: Christopher D. Whelan, Ph.D.Biogen Research and Early Development, Cambridge, MA.
Simina Ticau, Ph.D. Alnylam Pharmaceuticals, Cambridge, MA.

During the webinar, the speakers:

  • Described how multiplex biomarker screening identified signatures to distinguish early and established Alzheimer’s disease.
  • Explained how a broad screening of over 1,000 proteins identified multiple biomarkers in hATTR amyloidosis patients treated with an RNA interference therapeutic.
  • Shared results comparing correlation data for key protein biomarkers using two different profiling assays.

To access this webinar, as well as the rest of our categorized library of more than 20 high-quality scientific webinars featuring presentations by leading researchers in their respective fields, please click the button below.